Neuroscience

Prozac works better when used with other therapies

(Medical Xpress) -- The antidepressant fluoxetine, which is marketed under the name "Prozac," has been approved for use in the US for over two decades, and while some people find it effective, the results vary widely from ...

Medications

Study explains how antidepressant increases brain plasticity

A recent study, published in Neuropsychopharmacology, conducted by researchers from the University of Helsinki and the University of Eastern Finland, sheds light on the mechanisms of neural plasticity induced by the antidepressant ...

Medications

New target structure against coronavirus

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg ...

Diseases, Conditions, Syndromes

Common antidepressant may reduce deadly COVID-19 complications

As mental health professionals are grappling with a wave of pandemic-related anxiety and depression, a physician-researcher at The University of Toledo College of Medicine and Life Sciences is studying whether a commonly ...

Medications

Antidepressant does not improve post-stroke recovery

The antidepressant fluoxetine has been suggested as a means to improve brain recovery after acute stroke. However, a large randomized study on stroke patients at 35 Swedish hospitals shows that the drug has no such effect. ...

Neuroscience

How a popular antidepressant drug could rewire the brain

Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988. Thirty years later, scientists still don't know exactly how the medication exerts its mood-lifting ...

page 1 from 3

Fluoxetine

Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is manufactured and marketed by Eli Lilly and Company. In combination with olanzapine it is known as Symbyax.

Fluoxetine is approved for the treatment of major depression (including pediatric depression), obsessive-compulsive disorder (in both adult and pediatric populations), bulimia nervosa, panic disorder and premenstrual dysphoric disorder.

Despite the availability of newer agents, fluoxetine remains extremely popular. In 2010, over 24.4 million prescriptions for generic formulations of fluoxetine were filled in the United States alone, making it the third most prescribed antidepressant after sertraline (SSRI; became generic in 2006) and citalopram (SSRI; became generic in 2003) in that country.

This text uses material from Wikipedia, licensed under CC BY-SA